Compounds > dithiothreitol
Page last updated: 2024-08-22

dithiothreitol and sch 28080

dithiothreitol has been researched along with sch 28080 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dantzig, AH; Fukuda, DS; Garrigus, JL; Minor, PL; Mynderse, JS1
Beil, W; Schünemann, P; Sewing, KF; Staar, U1
Castrovilly, L; Scott, CK; Sundell, E1
Arikawa, Y; Hirase, K; Hori, Y; Imanishi, A; Inatomi, N; Kajino, M; Matsukawa, J; Nishida, H; Tsukimi, Y1

Other Studies

4 other study(ies) available for dithiothreitol and sch 28080

ArticleYear
Studies on the mechanism of action of A80915A, a semi-naphthoquinone natural product, as an inhibitor of gastric (H(+)-K+)-ATPase.
    Biochemical pharmacology, 1991, Oct-24, Volume: 42, Issue:10

    Topics: Adenosine Triphosphatases; Alkaline Phosphatase; Animals; Anti-Bacterial Agents; Dithiothreitol; Dose-Response Relationship, Drug; gamma-Glutamyltransferase; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Imidazoles; Kinetics; Naphthoquinones; Omeprazole; Potassium; Protein Conformation; Swine; Time Factors

1991
Omeprazole, SCH 28080 and doxepin differ in their characteristics to inhibit H+/K+-ATPase driven proton accumulation by parietal cell membrane vesicles.
    Biochemical pharmacology, 1988, Dec-01, Volume: 37, Issue:23

    Topics: Adenosine Triphosphatases; Animals; Dithiothreitol; Doxepin; Glutathione; H(+)-K(+)-Exchanging ATPase; Hydrogen; Imidazoles; Membranes; Omeprazole; Parietal Cells, Gastric; Swine

1988
Studies on the mechanism of action of the gastric microsomal (H+ + K+)-ATPase inhibitors SCH 32651 and SCH 28080.
    Biochemical pharmacology, 1987, Jan-01, Volume: 36, Issue:1

    Topics: Adenosine Triphosphatases; Aminopyrine; Animals; Bucladesine; Dithiothreitol; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Histamine; Imidazoles; Mercaptoethanol; Microsomes; Omeprazole; Pyrazines; Rabbits

1987
1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Dithiothreitol; Gastric Acid; Gastric Mucosa; Histamine; Hydrogen-Ion Concentration; Imidazoles; In Vitro Techniques; Kinetics; Lansoprazole; Ligation; Male; Potassium; Proton Pump Inhibitors; Pylorus; Pyrroles; Rats; Rats, Sprague-Dawley; Stomach; Sulfonamides; Swine

2010